Functional alteration of PARL contributes to mitochondrial dysregulation in Parkinson's disease
about
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)A comprehensive glossary of autophagy-related molecules and processes (2nd edition)Mitochondrial dynamics and mitophagy in Parkinson's disease: disordered cellular power plant becomes a big deal in a major movement disorderPINK1-Parkin pathway activity is regulated by degradation of PINK1 in the mitochondrial matrixMitochondrial protein quality control: the mechanisms guarding mitochondrial healthPINK1 is degraded through the N-end rule pathwayMitochondrial quality control mediated by PINK1 and Parkin: links to parkinsonism.PINK1 autophosphorylation upon membrane potential dissipation is essential for Parkin recruitment to damaged mitochondriaMitochondrial processing peptidase regulates PINK1 processing, import and Parkin recruitmentThe emerging role of proteolysis in mitochondrial quality control and the etiology of Parkinson's disease.Rhomboid domain containing 1 promotes colorectal cancer growth through activation of the EGFR signalling pathway.Spatial expression patterns of autophagy genes in the eye lens and induction of autophagy in lens cells.Intramembrane protease PARL defines a negative regulator of PINK1- and PARK2/Parkin-dependent mitophagyMacroautophagy in sporadic and the genetic form of Parkinson's disease with the A53T α-synuclein mutationDrosophila as a model to study mitochondrial dysfunction in Parkinson's disease.The ubiquitin signal and autophagy: an orchestrated dance leading to mitochondrial degradationPINK1- and Parkin-mediated mitophagy at a glance.PINK1 as a molecular checkpoint in the maintenance of mitochondrial function and integrityMitochondrial protein quality control in health and disease.Heterozygous PINK1 p.G411S increases risk of Parkinson's disease via a dominant-negative mechanism.Intramembrane proteolysis in regulated protein trafficking.Crosstalk between mitochondrial (dys)function and mitochondrial abundance.Rhomboid proteases in plants - still in square one?The rhomboid protease family: a decade of progress on function and mechanism.Parkin, PINK1 and mitochondrial integrity: emerging concepts of mitochondrial dysfunction in Parkinson's disease.Analysis of the regulatory and catalytic domains of PTEN-induced kinase-1 (PINK1).Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences.Structural and mechanistic principles of intramembrane proteolysis--lessons from rhomboids.Atypical protein phosphatases: emerging players in cellular signaling.Function and characteristics of PINK1 in mitochondria.Organellophagy: eliminating cellular building blocks via selective autophagy.New roles for mitochondrial proteases in health, ageing and disease.Alternative Processing of the Amyloid Precursor Protein Family by Rhomboid Protease RHBDL4.Intramembrane proteases as drug targets.Down-regulation of the mitochondrial matrix peptidase ClpP in muscle cells causes mitochondrial dysfunction and decreases cell proliferation.Mitochondrial Quality Control Proteases in Neuronal Welfare.The mitochondrial kinase PINK1: functions beyond mitophagy.PARL mediates Smac proteolytic maturation in mitochondria to promote apoptosis.Physiological functions and clinical implications of the N-end rule pathway.Site-2 protease responds to oxidative stress and regulates oxidative injury in mammalian cells.
P2860
Q22676705-C6F11F56-6299-4A0C-AF44-0139EAE4D0E3Q23757242-0F66DCA4-55AA-47BB-B854-F03998ECA39DQ27001551-64418C13-7989-42A6-BFF4-4AA2499DF7D9Q27316288-4BDB7288-F473-4592-A856-2C35DDDC66CDQ28083423-D2345154-4DC4-47E4-9FBC-A0E433C72DF2Q33638689-B04773D7-53B8-4574-8C04-BEEE862A1B36Q34309906-BFA0C83D-A888-4510-9B35-905C3F70FC0DQ34641661-BFD40DCF-26C9-4EA4-A5CF-747FBB8E80DBQ35874914-1553ED9E-A7D9-4032-87CE-5507F32DE632Q35986574-6A1DA5CA-8007-4814-8FF6-2AD29E906B69Q36030023-D80A4516-213D-457A-B5A0-DBB87D0CCB0AQ36099689-1A00B627-9552-402B-BBBC-C8AD30A6C4D0Q36111814-C1770F53-11BA-4B93-BC09-02CCD28C434DQ36424977-CD1B4ED4-0895-49CE-A339-8260EE79B188Q36526622-58EA7F8B-F580-4F4C-8830-E0A0C25C2811Q36636158-A82DB066-A311-41ED-A2D1-4E7DF6AB6A3FQ36851332-7C35B9FB-79D5-4A03-B4D9-D8615F3C4FB4Q37461824-8497F82E-CEA6-4971-A732-3052BDF5EDAAQ37686252-725D280D-FCA9-49BA-AE0A-2D20CC443521Q37736984-1647A3B3-F58C-41BC-AECF-A84803178EF5Q37876486-230FEFEB-8649-4D08-8E35-B8BB3E5AAB88Q37934748-6BBE3788-D9A8-430B-A274-2CA1744DE141Q37946954-55ABE53F-0853-453C-8217-A4828DDD8938Q37950553-8D25C412-70E1-456E-935B-D564EFBED5D5Q37953288-F5976E2B-E574-4821-8918-207E92C9DC4FQ38014338-49CFB214-179D-4DBD-A3D1-BB6EF5F6FC35Q38021865-678B8DE0-AB62-4964-92D9-E3225570889DQ38083850-EF67F6E1-E647-4465-A9F7-25A8EC251C69Q38084832-37AAE79B-1011-4E61-A38A-B04E018406CCQ38093581-834C5FDD-C401-467E-B26E-1F22FFDE0472Q38215011-4FDD6141-6263-4F2B-99A8-8EF21AF08688Q38477484-E90BE3C8-13EA-4341-8F8A-805C865403D9Q38749991-FE37CDD5-6259-4F1C-91A2-D8BA137978F6Q38790377-34E387D2-EC58-49D5-8D47-375E3188276AQ38807408-C39970CE-9497-47AB-AF0C-A2D868A774DAQ38823556-C910F781-A982-420E-9EE1-8EA1A0F13F2AQ38850628-DCD0B42C-2287-44FE-9523-23DA320B6DB7Q38911131-280D3123-3946-4173-98AF-A6BD081408B3Q38919056-463C12F4-B416-48A4-9566-53553C45D948Q38960315-95898852-3380-4C15-94F6-A2E0D183E353
P2860
Functional alteration of PARL contributes to mitochondrial dysregulation in Parkinson's disease
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Functional alteration of PARL ...... ulation in Parkinson's disease
@ast
Functional alteration of PARL ...... ulation in Parkinson's disease
@en
Functional alteration of PARL ...... ulation in Parkinson's disease
@en-gb
Functional alteration of PARL ...... ulation in Parkinson's disease
@nl
type
label
Functional alteration of PARL ...... ulation in Parkinson's disease
@ast
Functional alteration of PARL ...... ulation in Parkinson's disease
@en
Functional alteration of PARL ...... ulation in Parkinson's disease
@en-gb
Functional alteration of PARL ...... ulation in Parkinson's disease
@nl
prefLabel
Functional alteration of PARL ...... ulation in Parkinson's disease
@ast
Functional alteration of PARL ...... ulation in Parkinson's disease
@en
Functional alteration of PARL ...... ulation in Parkinson's disease
@en-gb
Functional alteration of PARL ...... ulation in Parkinson's disease
@nl
P2093
P2860
P921
P356
P1476
Functional alteration of PARL ...... ulation in Parkinson's disease
@en
P2093
Dennis E Bulman
G Angus McQuibban
Howard Yang
Jeffrey R Lee
Lemuel Racacho
Matthew Farrer
P2860
P304
P356
10.1093/HMG/DDR077
P407
P577
2011-05-15T00:00:00Z